Allworth Financial’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3K | Buy |
636
+300
| +89% | +$5.34K | ﹤0.01% | 2827 |
|
|
2025
Q1 | $6.23K | Sell |
336
-92
| -21% | -$1.71K | ﹤0.01% | 2638 |
|
|
2024
Q4 | $11.5K | Buy |
428
+7
| +2% | +$188 | ﹤0.01% | 2377 |
|
|
2024
Q3 | $6.58K | Sell |
421
-25
| -6% | -$391 | ﹤0.01% | 2445 |
|
|
2024
Q2 | $8.21K | Sell |
446
-602
| -57% | -$11.1K | ﹤0.01% | 2309 |
|
|
2024
Q1 | $16.4K | Sell |
1,048
-25
| -2% | -$391 | ﹤0.01% | 1884 |
|
|
2023
Q4 | $16K | Buy |
1,073
+929
| +645% | +$13.9K | ﹤0.01% | 1761 |
|
|
2023
Q3 | $2.33K | Buy |
+144
| New | +$2.33K | ﹤0.01% | 2464 |
|
|
2023
Q2 | – | Sell |
-33
| Closed | -$1.99K | – | 3336 |
|
|
2023
Q1 | $1.99K | Sell |
33
-185
| -85% | -$11.1K | ﹤0.01% | 2415 |
|
|
2022
Q4 | $16K | Sell |
218
-19
| -8% | -$1.39K | ﹤0.01% | 1483 |
|
|
2022
Q3 | $18K | Buy |
237
+28
| +13% | +$2.13K | ﹤0.01% | 1344 |
|
|
2022
Q2 | $15K | Buy |
209
+206
| +6,867% | +$14.8K | ﹤0.01% | 1369 |
|
|
2022
Q1 | $0 | Sell |
3
-186
| -98% | – | ﹤0.01% | 2291 |
|
|
2021
Q4 | $14K | Buy |
189
+105
| +125% | +$7.78K | ﹤0.01% | 1268 |
|
|
2021
Q3 | $10K | Buy |
+84
| New | +$10K | ﹤0.01% | 1339 |
|